|
STX12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.7387999999593E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.122540E-03 |
| Normal-vs-Stage2 |
1.312290E-02 |
| Normal-vs-Stage3 |
8.25880000054902E-07 |
| Normal-vs-Stage4 |
1.03980000054626E-07 |
| Stage1-vs-Stage2 |
6.096200E-01 |
| Stage1-vs-Stage3 |
3.062800E-03 |
| Stage1-vs-Stage4 |
9.642300E-04 |
| Stage2-vs-Stage3 |
2.021800E-01 |
| Stage2-vs-Stage4 |
1.233780E-01 |
| Stage3-vs-Stage4 |
5.875800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21150000000647E-05 |
| Normal-vs-AfricanAmerican |
6.33569999797245E-08 |
| Normal-vs-Asian |
2.133200E-01 |
| Caucasian-vs-AfricanAmerican |
3.383000E-03 |
| Caucasian-vs-Asian |
8.003400E-01 |
| AfricanAmerican-vs-Asian |
1.453770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.06649999995512E-06 |
| Normal-vs-Female |
2.000100E-04 |
| Male-vs-Female |
4.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.699640E-03 |
| Normal-vs-Age(41-60Yrs) |
7.973300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.04030000003252E-06 |
| Normal-vs-Age(81-100Yrs) |
1.158520E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.502400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.145800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.995000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.172400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.427800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.146000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.042800E-01 |
| Normal-vs-Grade 2 |
4.033600E-02 |
| Normal-vs-Grade 3 |
3.64700003530061E-09 |
| Normal-vs-Grade 4 |
4.3726999798821E-10 |
| Grade 1-vs-Grade 2 |
5.940200E-01 |
| Grade 1-vs-Grade 3 |
1.358480E-02 |
| Grade 1-vs-Grade 4 |
1.042400E-03 |
| Grade 2-vs-Grade 3 |
1.99317999999282E-05 |
| Grade 2-vs-Grade 4 |
7.31699999478863E-08 |
| Grade 3-vs-Grade 4 |
1.385710E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.397600E-01 |
| Normal-vs-ccB subtype |
7.63700003236778E-09 |
| ccA subtype-vs-ccB subtype |
1.21160004251664E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.38640000000246E-05 |
| Normal-vs-N1 |
2.540300E-03 |
| N0-vs-N1 |
2.774600E-01 |
|
|
